Extended, high dose VEGF antagonist regimens for treatment of angiogenic eye disorders
ZA202608799APending Publication Date: 2026-09-30REGENERON PHARMACEUTICALS INC +1
0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202608799
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-11-01
- Filing Date
- 2026-09-07
- Publication Date
- 2026-09-30
Abstract
NOT VISIBLE DUE TO STATUS OF PATENT
Need to check novelty before this filing date? Find Prior Art